Investing.com -- Glenmark Pharmaceuticals (NSE:GLEN) Inc., USA has launched the Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL), a product that is bioequivalent and therapeutically equivalent ...
Purpose: We investigated the intraocular pressure (IOP) variations after switching from 0.005% latanoprost to 0.01% bimatoprost in open-angle glaucoma patients who experienced IOP elevation during ...
Find all the commercial and brand names of generic drug called Latanoprost. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback